German Pharma Stock News

Over the past week, Bayer announced a slate of healthcare advances, including new clinical trials in rare kidney disease and women’s health, regulatory submissions for its imaging contrast agent gadoquatrane, and expanded U.S. clearance for its MEDRAD Centargo CT injector. Together, these moves highlight how Bayer is leaning on its pharmaceuticals and medical imaging pipeline to refresh growth drivers while addressing meaningful unmet medical needs. We’ll now explore how Bayer’s push into...

Münchener Rückversicherungs-Gesellschaft in München (XTRA:MUV2) has just reported fresh progress on its ongoing share buyback, detailing another batch of repurchases that nudges the total past 2.68 million shares. See our latest analysis for Münchener Rückversicherungs-Gesellschaft in München. The buyback update lands against a backdrop of steady gains, with a roughly 10 percent year to date share price return and a powerful 5 year total shareholder return of about 168 percent, signalling...

Wondering if SAP at around €210 is a bargain or a bubble? You are not alone, and this breakdown is going to tackle that value question head on. Over the last week the stock has inched up about 1.0%, but that is against a tougher backdrop of a 2.6% decline over 30 days and roughly 12.0% down year to date, after still being up more than 100% over three years. Recently, SAP has stayed in the spotlight as investors focus on its push to embed AI into its core enterprise software and its ongoing...

With a price-to-earnings (or "P/E") ratio of 14.5x Deutsche Post AG ( ETR:DHL ) may be sending bullish signals at the...

Infineon Technologies (XTRA:IFX) just scored a meaningful win in its GaN patent fight, with a U.S. trade judge preliminarily finding Innoscience in violation, and a potential import ban hanging over competing products. See our latest analysis for Infineon Technologies. That backdrop helps explain why momentum in Infineon’s 1 month share price return of 14.61 percent and 90 day share price return of 17.83 percent is building, even though the 1 year total shareholder return of 13.69 percent has...

Siemens Energy has appointed Hussein Shoukry as Managing Director for the Middle East and Africa, succeeding retiring veteran Dietmar Siersdorfer, and placed him in charge of regional operations spanning 29 offices, over 4,000 employees, and about €9.00 billion in fiscal 2025 order intake. At the same time, activist investor Ananym Capital has built a significant stake and is urging Siemens Energy to prioritize its gas turbine business and consider spinning off its weaker wind power segment,...

Key Insights Frequentis' significant private companies ownership suggests that the key decisions are influenced by...

To the annoyance of some shareholders, NFON AG ( ETR:NFN ) shares are down a considerable 25% in the last month, which...

Wondering if Volkswagen is still a value play after its recent run up, or if you are late to the party? Let us break down what the market is really pricing in and where the upside or downside might be hiding. Volkswagen's share price has climbed 5.6% over the last week, 13.4% over the past month, and is now up 22.3% year to date and 32.5% over the last year, which suggests investors are warming back up to the stock after a muted few years. Much of this momentum reflects renewed optimism...

If you are wondering whether Mercedes-Benz Group is still a value play after its strong run, or if the easy money has already been made, you are in the right place to unpack what the market is really pricing in. The stock has climbed 3.1% over the last week, 4.7% over the last month, and is up 18.4% over the past year, with a hefty 75.1% gain over five years that suggests the market has gradually been warming to its story. Recently, investors have been reacting to the company sharpening its...

In November 2025, FluoGuide A/S announced a non-exclusive collaboration agreement with ZEISS Medical Technologies to advance FG001 for tumor imaging and surgical margin assessment in head and neck cancer, focused on supporting the clinical phase and with no initial payment or expected financial impact in 2025. This partnership underlines Carl Zeiss Meditec’s continued push into precision oncology imaging, where integrating advanced optics with novel tracers could broaden its long-term...

Earlier this month, Beiersdorf Nigeria launched NIVEA’s largest-ever consumer engagement campaign, a ₦3.00 billion reward program with cash prizes, SUVs, travel experiences and other benefits designed to deepen loyalty in a challenging macroeconomic backdrop. The promotion’s link to NIVEA’s extended five-year partnership with Real Madrid highlights how the brand is tying high-profile sports marketing to on-the-ground incentives in a key African growth market. We’ll now examine how this...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

SAP (XTRA:SAP) has been drifting lower in recent months, and that pullback is starting to catch investor attention. With shares down double digits year to date, the key question is whether fundamentals still justify a fresh look. See our latest analysis for SAP. That slide in the share price, now around $210.1, comes after a strong multi year run. Recent weakness suggests momentum has cooled as investors reassess growth expectations and macro risk, even though the three year total shareholder...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Unfortunately for some shareholders, the The Platform Group AG ( ETR:TPG ) share price has dived 29% in the last thirty...

Knorr-Bremse's (ETR:KBX) stock is up by a considerable 13% over the past month. As most would know, fundamentals are...

As the European markets show mixed performance, with the pan-European STOXX Europe 600 Index edging higher on interest rate cut hopes, investors are increasingly exploring diverse opportunities within smaller market segments. Penny stocks, though often viewed as a relic of past trading days, continue to offer compelling prospects for those seeking growth at lower price points. These stocks typically represent smaller or newer companies and can provide significant value when backed by strong...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...

Key Insights Nagarro's estimated fair value is €79.62 based on 2 Stage Free Cash Flow to Equity Nagarro's €76.25 share...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

With a median price-to-earnings (or "P/E") ratio of close to 18x in Germany, you could be forgiven for feeling...

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 18x, you may consider...

DWS Group GmbH KGaA (XTRA:DWS) has delivered a strong run over the past year, yet recent weekly softness contrasts with its solid longer term gains and makes the current pullback interesting for valuation focused investors. See our latest analysis for DWS Group GmbH KGaA. With the share price now around $52.1, DWS’s recent 7 day share price pullback sits against a strong year to date share price return and an even more impressive multi year total shareholder return. This suggests momentum is...